Brian Casey[email protected]EconomicsStaffing costs continue to vex administrators in Q1 MICI dataConcerns about staffing costs continue to vex radiology administrators, according to data from the first quarter of 2022 in the Medical Imaging Confidence Index (MICI). Hospitals and radiology departments are facing both rising labor costs and staffing shortages.May 4, 2022HomeWeek in Review: PET beats MRI for meningioma | Ultrasound of lymphadenopathy | PACSman pontificatesApril 29, 2022HomeWeek in Review: New data on photon-counting CT | DEXA for arthroplasty | Dual-tracer PET/CTApril 22, 2022HomeWeek in Review: FDA advisory on AI | Costs of breast MRI | Handling disruptive radiologistsApril 15, 2022AIFDA says AI doesn't exclude LVO cases from radiologist reviewArtificial intelligence (AI) software shouldn't be used to rule out cases of intracranial large-vessel occlusion (LVO) from radiologist review, according to an advisory issued April 11 by the U.S. Food and Drug Administration.April 10, 2022HomeWeek in Review: Lessons learned from deploying AI | MRI of vaping | AI of CTC screeningApril 8, 2022Radiation Oncology/TherapyCMS again delays start of RO Model for radiation therapy paymentsA major restructuring of the way the U.S. Centers for Medicare and Medicaid Services (CMS) pay for radiation therapy treatments, the Radiation Oncology Alternative Payment Model (RO Model), has been delayed again -- this time into the indefinite future.April 5, 2022HomeWeek in Review: FDA warning on contrast | Breast density reporting | AMVC 2022 wrap-upApril 1, 2022CTFDA issues warning on iodinated contrast use in young kidsThe U.S. Food and Drug Administration (FDA) has added a new warning to the prescribing information for iodinated contrast media, advising of the health risk of contrast use in children younger than 3 years who have thyroid issues.March 29, 2022Molecular ImagingWeek in Review: Virtual conference March 30-31 | New prostate treatment | COVID and cancer screeningMarch 25, 2022Previous PagePage 5 of 140Next PageTop StoriesCTPET/CT identifies bone demineralization in breast cancer patientsPET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.MRIIs MRI in patients with retained metal fragments dangerous?Womens ImagingAI shows promise as second reader in breast cancer screeningResidents/FellowsRad residents show interest in global health imaging, but face barriersAIInvestigators test ChatGPT-4 Turbo for radiology AI monitoring
